(888) 552-6760 SCHEDULE AN APPOINTMENT

Samar Singh,

M.D.

Endocrinologist

Biography photo
Location
City of Hope Orange County Lennar Foundation Cancer Center
1000 Five Point
Irvine, CA 92618
Specialties
Diabetes, Endocrinology and Metabolism
Education
Medical school:
Degrees
  • 2003-2007,  Doctorate of Medicine, Brody School of Medicine; Greenville, NC
Fellowship
  • 2011-2013, Endocrinology, University of California, Irvine; Orange, CA
Residency
  • 2007-2010, Internal Medicine, University of California, Irvine; Orange, CA
Academic Appointments
  • Associate Clinical Professor, Department of Diabetes, Endocrinology & Metabolism
About Me

Raised in a household surrounded by physicians, Samar Singh, M.D. was inspired to pursue a career in medicine in order to have a positive impact on the lives of others. An endocrinologist and associate professor at City of Hope® Cancer Center Duarte, Dr. Singh is committed to helping patients ease the challenges of chronic metabolic conditions through a collaborative, person-centered approach. She prioritizes listening to her patients and ensuring that they understand their diagnoses and their treatment options. 

Dr. Singh earned her medical degree at East Carolina University’s Brody School of Medicine in Greenville, North Carolina, before completing her internal medicine residency and endocrinology fellowship at the University of California, Irvine, where she served as chief resident and was named fellow of the year. 

Before joining City of Hope, Dr. Singh was an associate clinical professor and program director for UC Irvine’s Department of Endocrinology. During her time there, she was recognized as one of the top 20 physicians for excellence in patient communication and was honored as a Southern California Top Doctors Rising Star. 

Fluent in Punjabi, Dr. Singh enjoys spending quality time with her family when she’s not in the clinic.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.